Innovative Debt Solutions
Tailored Growth Capital
Announcements
Claret Capital Partners Invests in SIS Medical, Marking 200th Portfolio Company
View Claret Capital Partners Invests in SIS Medical, Marking 200th Portfolio CompanyClaret Capital Partners Named Venture Debt Provider of the Year for Second Year Running!
View Claret Capital Partners Named Venture Debt Provider of the Year for Second Year Running!Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth
View Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate GrowthClaret Capital Partners Announces €10M Growth Funding in Yseop to Scale Generative AI Platform for Life Sciences and Pharma
View Claret Capital Partners Announces €10M Growth Funding in Yseop to Scale Generative AI Platform for Life Sciences and PharmaHow to (and How Not to) Raise Venture Debt (and maybe even Equity…)
View How to (and How Not to) Raise Venture Debt (and maybe even Equity…)Claret Capital Partners announces second close of the CEGCF IV (“Fund IV”) at over €350 million to invest in tech and life sciences
View Claret Capital Partners announces second close of the CEGCF IV (“Fund IV”) at over €350 million to invest in tech and life sciencesClaret Capital Partners backs SaaSrooms to accelerate growth
View Claret Capital Partners backs SaaSrooms to accelerate growthCytora acquired by Applied Systems accelerating the shared vision of delivering the Digital Roundtrip of Insurance
View Cytora acquired by Applied Systems accelerating the shared vision of delivering the Digital Roundtrip of InsuranceClaret Capital Partners invests €10M in Mindler to fuel growth through strategic M&A and market expansion
View Claret Capital Partners invests €10M in Mindler to fuel growth through strategic M&A and market expansionAI-Driven Surgical Robotics: The New Standard
View AI-Driven Surgical Robotics: The New StandardAbivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
View Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative ColitisFund your growth while minimising dilution
Investing in Europe's leading disruptive businesses.
€
0
bn+
Total capital deployed across Europe since inception.
€
0
bn+
AUM
0
+
European SMEs backed across technology, life sciences and climate tech.
Selected investments:
FOUNDER & CEO CORNER
Further Reading
Investment Announcement
14 Jan 2026
Claret Capital Partners Completes €35M Investment in Holidu to Fuel Growth and M&A
View Claret Capital Partners Completes €35M Investment in Holidu to Fuel Growth and M&A
Investment Announcement
8 Jan 2026
Claret Capital Partners Invests in SIS Medical, Marking 200th Portfolio Company
View Claret Capital Partners Invests in SIS Medical, Marking 200th Portfolio Company
Claret News
9 Nov 2025
Claret Capital Partners Named Venture Debt Provider of the Year for Second Year Running!
View Claret Capital Partners Named Venture Debt Provider of the Year for Second Year Running!
Investment Announcement
2 Oct 2025
Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth
View Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth
Investment Announcement
1 Oct 2025
Claret Capital Partners Announces €10M Growth Funding in Yseop to Scale Generative AI Platform for Life Sciences and Pharma
View Claret Capital Partners Announces €10M Growth Funding in Yseop to Scale Generative AI Platform for Life Sciences and Pharma
Claret Insight
30 Sep 2025
How to (and How Not to) Raise Venture Debt (and maybe even Equity…)
View How to (and How Not to) Raise Venture Debt (and maybe even Equity…)
Claret News
17 Sep 2025
Claret Capital Partners announces second close of the CEGCF IV (“Fund IV”) at over €350 million to invest in tech and life sciences
View Claret Capital Partners announces second close of the CEGCF IV (“Fund IV”) at over €350 million to invest in tech and life sciences
Investment Announcement
17 Sep 2025
Claret Capital Partners backs SaaSrooms to accelerate growth
View Claret Capital Partners backs SaaSrooms to accelerate growth
Portfolio News
9 Sep 2025
Cytora acquired by Applied Systems accelerating the shared vision of delivering the Digital Roundtrip of Insurance
View Cytora acquired by Applied Systems accelerating the shared vision of delivering the Digital Roundtrip of Insurance
Investment Announcement
27 Aug 2025
Claret Capital Partners invests €10M in Mindler to fuel growth through strategic M&A and market expansion
View Claret Capital Partners invests €10M in Mindler to fuel growth through strategic M&A and market expansion
Claret Insight
13 Aug 2025
AI-Driven Surgical Robotics: The New Standard
View AI-Driven Surgical Robotics: The New Standard
Portfolio News
22 Jul 2025